Sutro Biopharma (STRO) Preferred Stock Liabilities (2016 - 2018)

Sutro Biopharma (STRO) posted Preferred Stock Liabilities of $187.2 million for Q3 2018, up 82.67% sequentially from $102.5 million in Q4 2017.

Sutro Biopharma (STRO) Preferred Stock Liabilities (2016 - 2018) Analysis & Trends

Sutro Biopharma has reported Preferred Stock Liabilities for 3 years, with the latest figure at $187.2 million in Q3 2018.

Quarterly Preferred Stock Liabilities changed N/A year-over-year to $187.2 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $187.2 million (changed N/A YoY) and the FY2017 annual result came in at $102.5 million, changed 0.0% from the prior year.
Preferred Stock Liabilities advanced to $187.2 million in Q3 2018 per STRO's latest filing, from $102.5 million in the prior quarter.
Over five years, Preferred Stock Liabilities peaked at $187.2 million in Q3 2018 and troughed at $102.5 million in Q4 2016.
A 3-year average of $130.8 million and a median of $102.5 million in 2016 frame the typical range for Preferred Stock Liabilities.
The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2017, down 0.0% in 2017.
Over 3 years, Preferred Stock Liabilities stood at $102.5 million in 2016, then changed by 0.0% to $102.5 million in 2017, then soared by 82.67% to $187.2 million in 2018.
According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $187.2 million, $102.5 million, and $102.5 million for Q3 2018, Q4 2017, and Q4 2016 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Sutro Biopharma	339.58 Mn	175.24 Mn	-	-

Download Data